Caplyta (lumateperone) was approved for the treatment of schizophrenia in 2019 and for depressive episodes linked to bipolar I or bipolar II disorder (bipolar depression) in 2021. Caplyta can be ...

Researchers have used everyday Fitbit data to train a machine learning algorithm to accurately predict mood episodes ...

Balance Treatment Center offers a program designed to meet the needs of clients struggling with issues including depression, anxiety, bipolar disorder, psychosis, PTSD, substance abuse ...

Weissmann says that the study participants with bipolar disorder and those with depression were taking a range of medications, so if the algorithm was distinguishing people on the basis of their ...

Zurzuvae, the first pill approved by the FDA to treat postpartum depression, is helping women at Allegheny Health Network and ...

As such, a treatment plan for bipolar disorder prioritizes keeping the patient safe, ensuring the safety of those around them, and reducing the frequency and severity of episodes of depression and ...

However, stopping treatment with Caplyta may cause symptoms of schizophrenia or bipolar depression to return. (These are conditions that Caplyta is approved to treat.) If you have questions about ...

Bipolar disorder can impact cognitive ... do not meet clinical criteria for hypomania or depression. Related: Mania ...